{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:44:10Z","timestamp":1787237050049,"version":"build-2736575974"},"reference-count":19,"publisher":"The Endocrine Society","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>We administered the aromatase inhibitor fadrozole to 16 girls with gonadotropin-independent precocious puberty due to the McCune-Albright syndrome. The girls\u2019 ages ranged from 3.2\u20139.7 yr, and their bone ages ranged from 5.75\u201314.25 yr. After baseline evaluations, fadrozole was started at a dose of 240 \u03bcg\/kg\u00b7d (equivalent to the dose recommended for therapy of estrogen-dependent breast cancer) for 12\u201321 months and increased to 480 \u03bcg\/kg\u00b7d for an additional 12 months in 10 girls. During treatment, seven girls had evidence of central precocious puberty; hence, the GnRH agonist deslorelin (4 \u03bcg\/kg\u00b7d sc) was added to their regimen. One girl was on a long-acting GnRH agonist from the start of treatment. Patients were evaluated at 2\u20136-month intervals throughout treatment. After the first 6\u201312 months of treatment, fadrozole showed some benefits in 10 girls, including decrease in frequency of menses and\/or rates of linear growth and bone maturation; however, fadrozole had no significant benefit in the group as a whole. The seven girls with evidence of central precocious puberty had no slowing in the progression of their puberty during the combined fadrozole and GnRH analog treatment. Adverse effects of fadrozole included inhibition of cortisol and aldosterone biosynthesis at the dose of 480 \u03bcg\/kg\u00b7d, without clinical evidence of adrenal insufficiency. In addition, three patients complained of nonspecific abdominal pain during fadrozole treatment. In one patient, this resolved with a reduction in dose from 480 to 240 \u03bcg\/kg\u00b7d; in two patients, it resolved spontaneously. One girl had muscle weakness and constipation on the 480 \u03bcg\/kg\u00b7d. This resolved after discontinuation of the drug. We conclude that fadrozole is not sufficiently potent to block estrogen synthesis in most girls with gonadotropin-independent precocious puberty due to the McCune-Albright syndrome and may impair the adrenocortical stress response.<\/jats:p>","DOI":"10.1210\/jc.2003-030864","type":"journal-article","created":{"date-parts":[[2003,12,11]],"date-time":"2003-12-11T17:23:51Z","timestamp":1071163431000},"page":"5730-5733","source":"Crossref","is-referenced-by-count":28,"title":["Lack of Efficacy of Fadrozole in Treating Precocious Puberty in Girls with the McCune-Albright Syndrome"],"prefix":"10.1210","volume":"88","author":[{"given":"Susan B.","family":"Nunez","sequence":"first","affiliation":[{"name":"Children\u2019s National Medical Center (S.B.N.), Washington, D.C. 20010"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Calis","sequence":"additional","affiliation":[{"name":"Warren G. Maguson Clinical Center (K.C., J.J.), National Institutes of Health, Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Gordon B.","family":"Cutler","sequence":"additional","affiliation":[{"name":"Lilly Research Laboratories (G.B.C.), Eli Lilly and Company, Indianapolis, Indiana 46285"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Jones","sequence":"additional","affiliation":[{"name":"Warren G. Maguson Clinical Center (K.C., J.J.), National Institutes of Health, Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penelope P.","family":"Feuillan","sequence":"additional","affiliation":[{"name":"Developmental Endocrinology Branch (P.P.F.), National Institutes of Child Health and Human Development, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071613454270900_R1","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJM193704292161701","article-title":"Syndrome characterized by osteitis fibrosa disseminata, areas of pigmentation and endocrine dysfunction with precocious puberty in females: report of five cases.","volume":"216","author":"Albright","year":"1937","journal-title":"N Engl J Med"},{"key":"2020071613454270900_R2","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1056\/NEJM199112123252403","article-title":"Activating mutations of the stimulatory G protein in the McCune-Albright syndrome.","volume":"325","author":"Weinstein","year":"1991","journal-title":"N Engl J Med"},{"key":"2020071613454270900_R3","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1210\/jcem-58-6-1161","article-title":"Absence of pubertal gonadotropin secretion in girls with McCune-Albright syndrome.","volume":"58","author":"Foster","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613454270900_R4","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1210\/jcem-59-4-801","article-title":"Cyclic ovarian function resistant to treatment with luteinizing hormone releasing hormone in girls with McCune-Albright syndrome.","volume":"59","author":"Comite","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613454270900_R5","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0039-128X(83)90068-5","article-title":"In vitro and in vivo studies demonstrating potent and selective estrogen inhibition with the nonsteroidal aromatase inhibitor CGS 16949A.","volume":"50","author":"Steele","year":"1987","journal-title":"Steroids"},{"key":"2020071613454270900_R6","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1210\/jcem-68-1-99","article-title":"Inhibition of aromatase with CGS 16949A in postmenopausal women.","volume":"68","author":"Santen","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613454270900_R7","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0960-0760(92)90202-T","article-title":"Fadrozole hydrochloride, a new nontoxic aromatase inhibitor for the treatment of patients with metastatic breast cancer.","volume":"43","author":"Falkson","year":"1992","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2020071613454270900_R8","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/0960-0760(93)90282-2","article-title":"The effects of long-term fadrozole hydrochloride treatment in patients with advanced stage breast cancer.","volume":"44","author":"Demers","year":"1993","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2020071613454270900_R9","first-page":"571","article-title":"The effects of fadrozole hydrochloride on aldosterone secretion in healthy male subjects.","volume":"74","author":"Trunet","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613454270900_R10","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1148\/125.2.477","article-title":"Grey scale ultrasonography of the normal female pelvis.","volume":"125","author":"Sample","year":"1977","journal-title":"Radiology"},{"key":"2020071613454270900_R11","volume-title":"Radiographic atlas of skeletal development of the hand and wrist","author":"Greulich","year":"1950"},{"key":"2020071613454270900_R12","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0039-128X(71)90059-6","article-title":"Measurement of estrone sulfate in plasma.","volume":"18","author":"Loriaux","year":"1972","journal-title":"Steroids"},{"key":"2020071613454270900_R13","first-page":"164","article-title":"Radioimmunoassay for plasma testosterone.","volume":"10","author":"Nieschlag","year":"1972","journal-title":"Z Klin Chem Klin Biochem"},{"key":"2020071613454270900_R14","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1210\/endo-103-6-2112","article-title":"Adrenarche: a survey of rodents, domestic animals and primates.","volume":"103","author":"Cutler Jr","year":"1978","journal-title":"Endocrinology"},{"key":"2020071613454270900_R15","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1172\/JCI105527","article-title":"Radioimmunoassay for luteinizing hormone in human plasma or serum: physiological studies.","volume":"46","author":"Odell","year":"1967","journal-title":"J Clin Invest"},{"key":"2020071613454270900_R16","first-page":"1030","article-title":"Characterization of antisera for human follicle-stimulating hormone radioimmunoassay.","volume":"175","author":"Cargille","year":"1970","journal-title":"J Lab Clin Med"},{"key":"2020071613454270900_R17","first-page":"422","article-title":"Measurement of renin activity concentration and substrate in rat plasma by radioimmunoassay of angiotensin I.","volume":"98","author":"Menan","year":"1972","journal-title":"Endocrinology"},{"key":"2020071613454270900_R18","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1210\/jcem.84.1.5413","article-title":"Six-year results of spironolactone and testolactone treatment of familial male-limited precocious puberty with addition of deslorelin after central puberty.","volume":"84","author":"Leschek","year":"1999","journal-title":"J Clin Endcrinol Metab"},{"key":"2020071613454270900_R19","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/0960-0760(90)90460-3","article-title":"Highly selective inhibition of estrogen biosynthesis by CGS 20267, a new, nonsteroidal aromatase inhibitor.","volume":"37","author":"Bhatagnar","year":"1990","journal-title":"J Steroid Biochem Mol Biol"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/88\/12\/5730\/9060945\/jcem5730.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/88\/12\/5730\/9060945\/jcem5730.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T20:34:55Z","timestamp":1594931695000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/88\/12\/5730\/2661472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12,1]]},"references-count":19,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2003,12,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2003-030864","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,12,1]]}}}